Clinical trial No longer in our active list Observational Ages 18 and up

I-ONE therapy for pain relief after total knee replacement

Official title: Multicenter Prospective Observational Study in Patients With Painful Total Knee Replacement and I-one Therapy

Run by University Hospital of Ferrara · NCT06330454 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if I-ONE therapy can help reduce pain and swelling in patients who are recovering from total knee replacement surgery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment237 (estimated)
SponsorUniversity Hospital of Ferrara
Academic / other
Locations7 sites (Bologna, BO and 6 other locations)
Trial IDNCT06330454 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals who have undergone total knee replacement surgery and are experiencing moderate to severe pain without any signs of infection.

Probably not a fit

Patients with pain due to mechanical issues, previous knee infections, or systemic inflammatory diseases may not benefit from this therapy.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effectiveness of I-ONE therapy, a biophysical stimulation treatment, in reducing pain and inflammation in patients who have undergone total knee arthroplasty (TKA). It focuses on patients experiencing significant knee pain and swelling between 30 to 180 days post-surgery. The study aims to evaluate how I-ONE therapy can modulate inflammatory responses and improve functional recovery by targeting pro-inflammatory cytokines in the synovial fluid. By analyzing the relationship between inflammation and recovery, the study seeks to provide insights into new therapeutic strategies for post-operative care.

Why it matters

Potential benefit: If successful, this therapy could significantly reduce chronic pain and improve functional recovery for patients after knee replacement surgery.

How similar studies have gone: While the specific application of I-ONE therapy is novel, similar biophysical stimulation approaches have shown promise in managing post-surgical inflammation and pain.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* informed consent
* painful total knee replacement at least 30 ± 3 days post-op up to a maximum of 180 ± 3 days post-op
* VAS ≥ 5
* absence of infection

Exclusion Criteria:

* pain caused by mechanical problems (misalignment, mobilisation, etc.),
* the presence of hip prostheses,
* previous knee infections,
* rheumatoid arthritis
* autoimmune diseases
* systemic diseases
* tumours
* major axial deviations
* obesity (BMI \> 30 kg/m2).

Where it's running

  • IRCCS Istituto Ortopedico Rizzoli
    Bologna, Bo, Italy
    Recruiting
  • Poliambulanza Brescia
    Brescia, Bs, Italy
    Recruiting
  • Policlinico San Matteo Pavia
    Pavia, Pv, Italy
    Recruiting
  • Ospedale Mauriziano Torino
    Torino, To, Italy
    Recruiting
  • Ospedale Sacro Cuore Don Calabria Negrar Verona
    Negrar, Vr, Italy
    Recruiting
  • Policlinico di Bari
    Bari, Italy
    Recruiting
Show 1 more location
  • Ospedale Santo Spirito in Sassia/Ospedale San Filippo Neri Roma
    Roma, Italy
    Recruiting

Study contacts

  • Principal investigator: Leo Massari, MD — Azienda Ospedaliera-Universitaria Arcispedale S. Anna di Ferrara
  • Study coordinator: Leo Massari, MD
  • Email: msl@unife.it
  • Phone: +390532239797

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.